List of Inspire Pharmaceuticals patents

Patents where

Current Assignee

Name

Inspire Pharmaceuticals

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7531525 P	Patent 7531525 was granted and assigned to Inspire Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7531525	May 12, 2009
‌ US Patent 7109181 Joint lubrication with P2Y purinergic receptor agonists	Patent 7109181 was granted and assigned to Inspire Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7109181	September 19, 2006
‌ US Patent 7378082 Method for treating allergic rhinitis without adverse effects	Patent 7378082 was granted and assigned to Inspire Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7378082	May 27, 2008
‌ US Patent 6897201 Compositions and methods for the treatment of glaucoma or ocular hypertension	Patent 6897201 was granted and assigned to Inspire Pharmaceuticals on May, 2005 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	6897201	May 24, 2005
‌ US Patent 7749980 Non-nucleotide compositions and method for treating pain	Patent 7749980 was granted and assigned to Inspire Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7749980	July 6, 2010
‌ US Patent 7528119 Di(uridine 5′-)tetraphosphate and salts thereof	Patent 7528119 was granted and assigned to Inspire Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7528119	May 5, 2009
‌ US Patent 7247623 Method of treating dry eye disease with non-drying antihistamines	Patent 7247623 was granted and assigned to Inspire Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7247623	July 24, 2007
‌ US Patent 7320974 Cytoskeletal active compounds, compositions and use	Patent 7320974 was granted and assigned to Inspire Pharmaceuticals on January, 2008 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7320974	January 22, 2008
‌ US Patent 7018985 Composition and method for inhibiting platelet aggregation	Patent 7018985 was granted and assigned to Inspire Pharmaceuticals on March, 2006 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7018985	March 28, 2006
‌ US Patent 7368438 Non-nucleotide compositions and method for inhibiting platelet aggregation	Patent 7368438 was granted and assigned to Inspire Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7368438	May 6, 2008
‌ US Patent 7612047 Degradation-resistant mononucleoside phosphate compounds	Patent 7612047 was granted and assigned to Inspire Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7612047	November 3, 2009
‌ US Patent 7115585 Compositions for treating epithelial and retinal tissue diseases	Patent 7115585 was granted and assigned to Inspire Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7115585	October 3, 2006
‌ US Patent 7091334 Method for large-scale production of di(uridine 5′)-tetraphosphate and salts thereof	Patent 7091334 was granted and assigned to Inspire Pharmaceuticals on August, 2006 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7091334	August 15, 2006
‌ US Patent 7414137 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones	Patent 7414137 was granted and assigned to Inspire Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7414137	August 19, 2008
‌ US Patent 7335648 Non-nucleotide composition and method for inhibiting platelet aggregation	Patent 7335648 was granted and assigned to Inspire Pharmaceuticals on February, 2008 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7335648	February 26, 2008
‌ US Patent 7432252 Method of promoting cervical and vaginal secretions	Patent 7432252 was granted and assigned to Inspire Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7432252	October 7, 2008
‌ US Patent 7666861 Cytoskeletal active compounds, composition and use	Patent 7666861 was granted and assigned to Inspire Pharmaceuticals on February, 2010 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7666861	February 23, 2010
‌ US Patent 7741473 Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles	Patent 7741473 was granted and assigned to Inspire Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7741473	June 22, 2010
‌ US Patent 7932376 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation	Patent 7932376 was granted and assigned to Inspire Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7932376	April 26, 2011
‌ US Patent 7947850 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones	Patent 7947850 was granted and assigned to Inspire Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7947850	May 24, 2011
‌ US Patent 7939510 Di(uridine 5′-)tetraphosphate and salts thereof	Patent 7939510 was granted and assigned to Inspire Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7939510	May 10, 2011
‌ US Patent 7504497 Orally bioavailable compounds and methods for inhibiting platelet aggregation	Patent 7504497 was granted and assigned to Inspire Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7504497	March 17, 2009
‌ US Patent 7592445 Non-nucleotide composition and method for inhibiting platelet aggregation	Patent 7592445 was granted and assigned to Inspire Pharmaceuticals on September, 2009 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7592445	September 22, 2009
‌ US Patent 7223744 Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof	Patent 7223744 was granted and assigned to Inspire Pharmaceuticals on May, 2007 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7223744	May 29, 2007
‌ US Patent 7452870 Drug-eluting stents coated with P2Y	Patent 7452870 was granted and assigned to Inspire Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office.	Inspire Pharmaceuticals	United States Patent and Trademark Office	7452870	November 18, 2008

Results per page:

44 results

0 selected

44 results

0 selected